Cabot Co. (NYSE:CBT – Get Free Report) has been given a consensus rating of “Hold” by the five brokerages that are currently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $90.17.
Several research firms have recently commented on CBT. StockNews.com lowered Cabot from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, February 14th. UBS Group downgraded Cabot from a “buy” rating to a “neutral” rating and dropped their target price for the company from $90.00 to $87.00 in a research report on Monday, January 8th. Mizuho assumed coverage on shares of Cabot in a research note on Wednesday, March 27th. They issued a “buy” rating and a $104.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft downgraded shares of Cabot from a “buy” rating to a “hold” rating and upped their target price for the stock from $88.00 to $95.00 in a research note on Thursday, April 18th.
Read Our Latest Analysis on CBT
Insider Activity at Cabot
Institutional Trading of Cabot
A number of institutional investors have recently bought and sold shares of CBT. EverSource Wealth Advisors LLC raised its position in shares of Cabot by 143.1% during the 4th quarter. EverSource Wealth Advisors LLC now owns 333 shares of the specialty chemicals company’s stock worth $28,000 after acquiring an additional 196 shares in the last quarter. Arlington Trust Co LLC acquired a new stake in Cabot during the fourth quarter worth approximately $34,000. Hexagon Capital Partners LLC lifted its position in shares of Cabot by 81.8% during the 4th quarter. Hexagon Capital Partners LLC now owns 460 shares of the specialty chemicals company’s stock worth $38,000 after buying an additional 207 shares during the last quarter. SRS Capital Advisors Inc. boosted its holdings in shares of Cabot by 372.0% in the 4th quarter. SRS Capital Advisors Inc. now owns 505 shares of the specialty chemicals company’s stock valued at $42,000 after buying an additional 398 shares in the last quarter. Finally, GAMMA Investing LLC purchased a new position in shares of Cabot in the 4th quarter valued at $44,000. 93.18% of the stock is owned by hedge funds and other institutional investors.
Cabot Stock Performance
NYSE CBT opened at $92.72 on Thursday. The stock has a fifty day simple moving average of $88.53 and a 200-day simple moving average of $80.00. The company has a current ratio of 2.04, a quick ratio of 1.30 and a debt-to-equity ratio of 0.74. The stock has a market cap of $5.14 billion, a PE ratio of 12.04, a P/E/G ratio of 0.97 and a beta of 1.28. Cabot has a twelve month low of $63.73 and a twelve month high of $98.34.
Cabot (NYSE:CBT – Get Free Report) last announced its earnings results on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.07. Cabot had a net margin of 11.24% and a return on equity of 25.52%. The company had revenue of $958.00 million during the quarter, compared to analyst estimates of $927.28 million. Equities analysts anticipate that Cabot will post 6.58 earnings per share for the current year.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Stories
- Five stocks we like better than Cabot
- How to Most Effectively Use the MarketBeat Earnings Screener
- It’s Time to Buy Into the Super Micro Computer Stock Implosion
- Using the MarketBeat Dividend Tax Calculator
- Merger or Not, Albertson’s Companies is a Good Buy
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Cheap Stocks That Shouldn’t Be So
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.